BCM
ALNY icon

BlueCrest Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

BlueCrest Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,231
Closed -$561K – 173
2025
Q3 		$561K Buy
+1,231
New +$501K 0.03% 165
2018
Q4 		– Sell
-3,377
Closed -$296K – 844
2018
Q3 		$296K Buy
+3,377
New +$340K 0.01% 1047
2018
Q1 		– Sell
-4,529
Closed -$575K – 1463
2017
Q4 		$575K Sell
4,529
-11,426
-72% -$1.44M 0.02% 496
2017
Q3 		$1.88M Sell
15,955
-392
-2% -$33.5K 0.09% 262
2017
Q2 		$1.3M Buy
+16,347
New +$1.04M 0.05% 418
2016
Q1 		– Sell
-4,460
Closed -$420K – 766
2015
Q4 		$420K Buy
+4,460
New +$414K 0.02% 628

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM